Furthermore, in relation to nephropathic diseases, reduced Klotho has been associated with increased adverse clinical outcomes in patients with chronic kidney disease (CKD), including elevated creatinine levels, CKD progression and CKD-mineral bone disease (5–7). The gene discussed is KL; the disease is chronic kidney disease.